USE OF THE SEQUENCE ENCODING OF THE CARBOXYL-TERMINAL DOMAIN OF THE HEAVY CHAIN OF THE TETANUS TOXIN AS A DRUG

摘要

The invention relates to the use of the sequence encoding the carboxyl-terminal end domain of the heavy chain of the tetanus toxin as a drug, preferably in the treatment of amyotrophic lateral sclerosis (ALS), as well as the polypeptide encoded by said sequence for the treatment of the aforementioned disease.